SCHEMBL29638554

SCHEMBL29638554

COc1ccc(Nc2nccc3c(NC(=O)c4cnc5c(N)ncnn45)c(C)ccc23)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ RAF1 P04049 8/20 0.51
▸ BRAF P15056 8/20 0.51
▸ CSF1R P07333 5/20 0.51
▸ DDR1 Q08345 5/20 0.51
▸ DDR2 Q16832 5/20 0.51
▸ PIP4K2A P48426 9/20 0.44
▸ MAPT P10636 4/20 0.43
▸ ARAF P10398 1/20 0.42
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ POLB P06746 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25372676 1.00 RAF1 (0.51) RAF1BRAFCSF1RDDR1DDR2
SCHEMBL24399605 0.89 RAF1 (0.63) RAF1BRAFCSF1RDDR1DDR2
SCHEMBL29638514 0.89 RAF1 (0.63) RAF1BRAFCSF1RDDR1DDR2
SCHEMBL29638605 0.86 RAF1 (0.62) RAF1BRAFCSF1RDDR1DDR2
SCHEMBL24399635 0.86 RAF1 (0.62) RAF1BRAFCSF1RDDR1DDR2
SCHEMBL24399601 0.81 BRAF (0.49) RAF1BRAFCSF1RDDR1DDR2
SCHEMBL29638591 0.81 BRAF (0.49) RAF1BRAFCSF1RDDR1DDR2
SCHEMBL24399631 0.81 RAF1 (0.64) RAF1BRAFCSF1RDDR1DDR2
SCHEMBL24399761 0.81 BRAF (0.56) RAF1BRAFCSF1RDDR1DDR2
SCHEMBL29638586 0.81 BRAF (0.56) RAF1BRAFCSF1RDDR1DDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116096718-A Aryl amide compound, pharmaceutical composition containing same, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-05-09 — — CN disclosed
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 — — WO disclosed
Send feedback